World class resources for first class analysis.

Enlighten Health Genomics provides sequencing-based diagnostic and interpretation to help make genomics a routine part of the clinical decision-making process.

Contact and Connect


Enlighten Health Genomics builds on the diagnostic potential of next-generation sequencing technology combining the world-class infrastructure and capabilities of LabCorp with a team of accomplished geneticists. Offering state-of-the-art diagnostic capabilities, NGS analysis and interpretation, and informed genetic counseling, we aim to help enhance treatment decisions, lower healthcare costs and improve patient outcomes.


Increasing evidence suggests early genetic diagnosis can make a difference to clinical outcomes. EnlightenHealth Genomics offers:

  • State of the art diagnostic capabilities, including the soon-to-be-launched ExomeReveal whole exome sequencing testing service
  • Next-generation sequencing analysis and interpretation
  • Access to a team of genetic counselors available for physician/patient consultations before and after testing

ExomeReveal Genetic Coverage Tool

This tool allows you to search by gene to determine the percent coverage Enlighten Health Genomics’ ExomeReveal test offers to screen for a particular gene.

Search Now

Scientific Advisory Board

The Enlighten Health Genomics Scientific Advisory Board helps incorporate rapidly advancing science and provides a potential pathway for basic research studies. Consisting of national experts who will help ensure the work performed is of the highest possible standards, the board provides a mechanism to allow research studies to be launched to further explore some of the most interesting findings from the diagnostic work, including both the identification of novel genes and novel genetic mechanisms in known genes.


Dr. David Goldstein, Professor of Molecular Genetics & Microbiology, Professor of Biology and Director of the Center for Human Genome Variation at Duke University